News & Training

Staburo news about trainings, events and more

Workshop Staburo 3DSE Biostatistics Strategy 2022

With the support of Dr. Thilo Pfletschinger from 3DSE, we developed the company strategy for Staburo for the next five years. Before the workshop, all employees gave input to possible goals and the prospects of Staburo. The final strategy includes all our common goals...

read more

New member of the Staburo team

We are very happy to welcome Laura Schlieker in our team. Laura will support our clients with her experience in biostatistics, especially within the area of Translational Medicine & Biomarkers. We are looking forward to a great cooperation!...

read more

Staburo biostatistics support in diabetes trial

Another publication with Staburo biostatistics support, this time in diabetes type 2. Background: Studies of dipeptidyl peptidase (DPP)-4 inhibitors report heterogeneous effects on endothelial function in patients with type 2 diabetes (T2D). This study assessed the...

read more

You need support in statistics?

Contact us!